<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Helwick, Caroline</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Feeny, Nora C</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">PTSD Treatment is More Effective When Patients are Actively Involved in Therapy Choices</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">16-17</style></pages><abstract><style  face="normal" font="default" size="100%">A study of two standard therapies for post-traumatic stress disorder (PTSD) showed that outcomes are better when patient preference is taken into account when prescribing treatment. While treatment with a selective serotonin reuptake inhibitor (SSRI) and treatment via prolonged exposure were both effective in the study, the best outcomes were observed in patients who were actively involved in treatment selection.</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">10</style></volume></record></records></xml>